January 30, 2015 5:37 PM ET


Company Overview of Dance BioPharm Inc.

Company Overview

Dance Biopharm Inc., a development stage biopharmaceutical company, focuses on the development of inhaled insulin products for the treatment of diabetes worldwide. Its lead product candidate includes Dance 501, a drug/device combination product to deliver a high purity liquid insulin formulation through a small handheld electronic inhaler that has completed Phase II clinical trials in adult patients with type 2 diabetes. The company was formerly known as Dance Pharmaceuticals, Inc. and changed its name to Dance Biopharm Inc. in February 2013. Dance Biopharm Inc. was founded in 2009 and is based in Brisbane, California.

150 North Hill Drive

Suite 24

Brisbane, CA 94005

United States

Founded in 2009

17 Employees



Key Executives for Dance BioPharm Inc.

Age: 66
Chief Financial Officer
Age: 43
Executive Vice President of Operations and Quality
Age: 61
Chief Business Officer and Director
Age: 49
Chief Medical Officer
Age: 50
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
BSF AG Research Inc. United States
Mendel Biological Solutions United States
Wellstat Biologics Corporation United States
Rosetta Genomics Inc. United States
PNP Therapeutics, Inc. United States

Recent Private Companies Transactions

Private Placement
December 19, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Dance BioPharm Inc., please visit www.dancebiopharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.